JENNIFER MIRA: Open Payments
NPI 1346707981 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 51 payments from 19 companies in 2025. Trend: 2023 $577 · 2024 $768 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $148 |
| PFIZER INC. | 9 | $143 |
| Neurocrine BioSciences, Inc. | 2 | $112 |
| Astellas Pharma US Inc | 5 | $94 |
| Exact Sciences Corporation | 4 | $69 |
| Lilly USA, LLC | 4 | $58 |
| Amgen Inc. | 4 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| ABBVIE INC. | 3 | $51 |
| Novo Nordisk Inc | 2 | $40 |
Products named: BREZTRI, NURTEC ODT, INGREZZA, Veozah, Cologuard Collection Kit, Kerendia, MOUNJARO, Ozempic.
Industry payments across AR — which companies pay providers there.
